Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has filed its quarterly financial results with the NSE for the three-month period ending September 30, 2025. The headline announces only the act of submission; no specific revenue, profit, or margin figures are mentioned in the filing notice itself. Investors would need to review the detailed results statement for actual numbers and segment performance. This is a standard regulatory compliance filing required of listed companies after each quarter ends.
The announcement is procedural and confirms timely compliance with disclosure norms. Share price reaction, if any, will depend on the actual numbers inside the results document rather than this submission notice.